These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24585365)

  • 1. Plasmapheresis combined with rituximab for refractory idiopathic membranous nephropathy.
    Wen M; Küchle C; Sarkar O; Renders L; Heemann U; Schmaderer C
    Int Urol Nephrol; 2014 Apr; 46(4):847-8. PubMed ID: 24585365
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy.
    Zhu B; Huang J
    Pediatr Nephrol; 2011 Apr; 26(4):637-8. PubMed ID: 21046167
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab in membranous nephropathy: is it a first-line treatment?
    Appel GB
    J Am Soc Nephrol; 2012 Aug; 23(8):1280-2. PubMed ID: 22797189
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful therapeutic use of rituximab in refractory membranous glomerulonephritis.
    Cobo M; Hernández D; Rodriguez C; Pérez-Tamajón L
    Clin Nephrol; 2006 Jul; 66(1):54-7. PubMed ID: 16878436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of idiopathic membranous nephropathy.
    Waldman M; Austin HA
    J Am Soc Nephrol; 2012 Oct; 23(10):1617-30. PubMed ID: 22859855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment-resistant elephantiasic thyroid dermopathy responding to rituximab and plasmapheresis.
    Heyes C; Nolan R; Leahy M; Gebauer K
    Australas J Dermatol; 2012 Feb; 53(1):e1-4. PubMed ID: 22309343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab in a B cell-driven regimen for the treatment of recurrent membranoproliferative glomerulonephritis after kidney transplantation.
    Marques ID; Ramalho J; David DR; Nahas WC; David-Neto E
    Int Urol Nephrol; 2014 Oct; 46(10):2053-4. PubMed ID: 25080208
    [No Abstract]   [Full Text] [Related]  

  • 8. Membranous nephropathy.
    Mathieson PW
    Clin Med (Lond); 2012 Oct; 12(5):461-6. PubMed ID: 23101149
    [No Abstract]   [Full Text] [Related]  

  • 9. Rituximab treatment of idiopathic membranous nephropathy.
    Fervenza FC; Cosio FG; Erickson SB; Specks U; Herzenberg AM; Dillon JJ; Leung N; Cohen IM; Wochos DN; Bergstralh E; Hladunewich M; Cattran DC
    Kidney Int; 2008 Jan; 73(1):117-25. PubMed ID: 17943078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab in idiopathic membranous nephropathy.
    Ruggenenti P; Cravedi P; Chianca A; Perna A; Ruggiero B; Gaspari F; Rambaldi A; Marasà M; Remuzzi G
    J Am Soc Nephrol; 2012 Aug; 23(8):1416-25. PubMed ID: 22822077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab in primary membranous nephropathy: first-line therapy, why not?
    Cravedi P; Remuzzi G; Ruggenenti P
    Nephron Clin Pract; 2014; 128(3-4):261-9. PubMed ID: 25427622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique way to treat Goodpasture's disease.
    Narayanan M; Casimiro I; Pichler R
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25422333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab In The Treatment Of Refractory Idiopathic Membranous Nephropathy In Pakistani Population.
    Anjum N; Nabi Z; Alam MA
    J Ayub Med Coll Abbottabad; 2019; 31(2):265-268. PubMed ID: 31094128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membranous nephropathy: the start of a paradigm shift.
    Herrmann SM; Sethi S; Fervenza FC
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):203-10. PubMed ID: 22240444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Ormond Disease and Idiopathic Membranous Glomerulonephritis by using Rituximab.
    Dedinská I; Svetlík D; Adamicova K; Machalekova K; Makovicky P; Jezikova A; Laca L; Miklusica J; Galajda P; Mokan M
    Iran J Kidney Dis; 2016 Sep; 10(5):332-335. PubMed ID: 27721233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membranous nephropathy: a rare renal manifestation of IgG4-related systemic disease.
    Jindal N; Yadav D; Passero C; Krasinskas A; Craig F; Bastacky S; Liang KV
    Clin Nephrol; 2012 Apr; 77(4):321-8. PubMed ID: 22445476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for membranous nephropathy and immune disease: less might be enough.
    Ruggenenti P; Cravedi P; Remuzzi G
    Nat Clin Pract Nephrol; 2009 Feb; 5(2):76-7. PubMed ID: 19048001
    [No Abstract]   [Full Text] [Related]  

  • 18. Rituximab in immunologic glomerular diseases.
    Ejaz AA; Asmar A; Alsabbagh MM; Ahsan N
    MAbs; 2012; 4(2):198-207. PubMed ID: 22377738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab: emerging treatment strategies of immune-mediated glomerular disease.
    Kattah AG; Fervenza FC
    Expert Rev Clin Immunol; 2012 Jul; 8(5):413-21. PubMed ID: 22882216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab therapy in two children with autoimmune thrombotic thrombocytopenic purpura.
    Albaramki JH; Teo J; Alexander SI
    Pediatr Nephrol; 2009 Sep; 24(9):1749-52. PubMed ID: 19399522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.